Budesonide Inhalation Suspension
Product Images NDC 68788-8429

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68788-8429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Budesonide Inhalation Suspension 0.25mg Per 2ml (1d139a25 9c17 4b3e 8ffd B2d562cc00ee 00)

Budesonide Inhalation Suspension 0.25mg Per 2ml (1d139a25 9c17 4b3e 8ffd B2d562cc00ee 00)
This text is a description of Budesonide Inhalation Suspension, a generic medicine used to treat respiratory problems such as asthma and COPD. The suspension comes in ampoules, with each individual ampoule holding 2ml of a sterile suspension containing 0.25mg of micronized budesonide. It's manufactured by Amneal Pharmaceuticals, and must be stored upright at a temperature between 20°C and 25°C. Each package comes with a lot number, batch number, and expiration date. The text includes instructions in both English and Spanish, cautioning against the transfer of the drug to anyone other than the patient it was prescribed to. The cost is presumably covered by health insurance.*
FDA Label Image

Chemical Structure Formula Of Budesonide (Budesonide Inhalation Suspension 1)

Chemical Structure Formula Of Budesonide (Budesonide Inhalation Suspension 1)
FDA Label Image

Figure 1: A 12-week Trial In Pediatric Patients Previously Maintained On Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 2)

Figure 1: A 12-week Trial In Pediatric Patients Previously Maintained On Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 2)
This text appears to be a chart or graph displaying the mean change from baseline nighttime asthma symptoms during a 12-week period. It includes measurements taken during different intervals, indicated by different weeks, ranging from week 0 to week 12. Placebo and two different doses of medication (0.25 mg and 0.5 mg, taken twice daily) are indicated. However, without additional context or a visual representation of the chart, it is difficult to fully interpret or provide more specific information.*
FDA Label Image

Figure 2: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 3)

Figure 2: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 3)
This is a chart representing the progress of nighttime asthma symptoms over a period of 12 weeks, categorized by the type of medication taken. The medication used is either a placebo or a 0.25mg or 0.5mg dose, taken twice daily. There are no further details available.*
FDA Label Image

Figure 1 Open The Sealed Foil Envelope Along The Dotted Line And Take Out 1 Single-dose Ampule From The Strip. (Budesonide Inhalation Suspension 4)

Figure 1 Open The Sealed Foil Envelope Along The Dotted Line And Take Out 1 Single-dose Ampule From The Strip. (Budesonide Inhalation Suspension 4)
FDA Label Image

Figure 2 Gently Shake The Budesonide Inhalation Suspension Ampule Using A Circular Motion (Budesonide Inhalation Suspension 5)

Figure 2 Gently Shake The Budesonide Inhalation Suspension Ampule Using A Circular Motion (Budesonide Inhalation Suspension 5)
FDA Label Image

Figure 3 Hold The Budesonide Inhalation Suspension Ampule Upright Without Squeezing The Ampule And Open By Twisting Off The Top. (Budesonide Inhalation Suspension 6)

Figure 3 Hold The Budesonide Inhalation Suspension Ampule Upright Without Squeezing The Ampule And Open By Twisting Off The Top. (Budesonide Inhalation Suspension 6)
FDA Label Image

4. Place The Open End Of The Budesonide Inhalation Suspension Ampule Into The Nebulizer Cup (reservoir) And Slowly Squeeze All Of The Medicine From The Ampule Into The Nebulizer Medicine Cup As Shown In Figure 4. Throw Away The Empty Ampule. (Budesonide Inhalation Suspension 7)

4. Place The Open End Of The Budesonide Inhalation Suspension Ampule Into The Nebulizer Cup (reservoir) And Slowly Squeeze All Of The Medicine From The Ampule Into The Nebulizer Medicine Cup As Shown In Figure 4. Throw Away The Empty Ampule. (Budesonide Inhalation Suspension 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.